AVS Bio

Executive Summary

AVS Bio is a San Diego-based private biologics company founded in 2015 that leverages over 60 years of legacy experience in avian biologicals. The company accelerates discovery and development through avian-derived biological materials, custom proteins, and antibodies, serving human, animal, and environmental health applications including vaccines, diagnostics, and therapeutics. With USDA-licensed manufacturing capabilities, AVS Bio provides essential products and services to support research and development across multiple sectors. The company is currently in the pre-clinical stage, focusing on advancing its proprietary platform and expanding its product portfolio. AVS Bio's unique avian-based technology offers advantages in production efficiency and safety, positioning it to address unmet needs in infectious diseases and other therapeutic areas. The company's broad applicability and established manufacturing infrastructure provide a foundation for future growth and partnerships.

Upcoming Catalysts (preview)

• Q3 2026Lead candidate advances to IND-enabling studies60% success
• Q4 2026Strategic partnership or licensing deal for avian platform50% success
• Q2 2026Expansion of USDA-licensed manufacturing capacity70% success